Document:

EXTENSION
OF MATURITY DATE FOR

PROMISSORY
NOTE

 

This
Extension of Maturity Date for Promissory Note (the “Extension”) dated February 19, 2015, is entered into by and between
CareView-Saline, LLC, a Wisconsin limited liability company (“Maker”) and Rockwell Holdings I, LLC (“Holder”)
(collectively known as the “Parties”).

 

WHEREAS,
the pursuant to a certain Master Investment Agreement entered into by the Parties on November 16, 2009, Maker issued to Holder
a Promissory Note in the principal amount of $109,230with respect to the Project (as defined in the Master Investment Agreement)
for the Saline Memorial Hospital,

 

WHEREAS,
the Promissory Note has a maturity date of three years from the date payments commenced thereunder, which would make the maturity
date of the Promissory Note August 30, 2013,

 

WHEREAS,
the maturity date of the Promissory Note was subsequently extended to December 31, 2013, then to June 30, 2014, and then to June
30, 2015,

 

WHEREAS,
the Parties have mutually agreed to extend the maturity date to June 30, 2016,

 

NOW,
THEREFORE, in consideration of the mutual covenants hereinafter set forth, the Parties hereby enter into this Extension as follows:

 

1.    Extension
of Maturity Date for Promissory Note: The Parties agree to extend the maturity date of the Promissory Note to June 30, 2016 (the
“Extended Maturity Date”).

 

2.    Other
Provisions of the Promissory Note: The Parties agree that all other provisions of the Promissory Note will remain in full force
and effect other than the Extended Maturity Date.

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the day and year first above written.

  

	CAREVIEW-SALINE, LLC	 	ROCKWELL HOLDINGS I, LLC
	 	 	 	 	 
	By:	 /s/
    Steve Johnson	 	By:	 /s/
    Matt Bluhm
	 	Steve Johnson	 	 	Matt Bluhm
	 	Manager	 	 	Managing MemberExecution

Sixth
AMENDMENT TO

NOTE AND WARRANT PURCHASE AGREEMENT

This SIXTH
AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT, dated as of March 31, 2015 (this
“Amendment”), is made by and among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (the
“Company”), and the undersigned investors (together with their respective successors and permitted
assigns, the “Investors”).

WITNESSETH:

WHEREAS,
the Company, HealthCor Partners Fund, L.P. (“HealthCor Partners”), HealthCor Hybrid Offshore Master Fund, L.P.
(“HealthCor Hybrid” and, together with HealthCor Partners, the “HealthCor Parties”), and
certain additional investors are party to that certain Note and Warrant Purchase Agreement, dated as of April 21, 2011 (as amended
from time to time, including without limitation pursuant to that certain Note and Warrant Amendment Agreement dated December 20,
2011, that certain Second Amendment to Note and Warrant Purchase Agreement dated January 31, 2012, that certain Third Amendment
to Note and Warrant Purchase Agreement dated August 20, 2013, that certain Fourth Amendment to Note and Warrant Purchase Agreement
dated January 16, 2014, and that certain Fifth Amendment to Note and Warrant Purchase Agreement dated December 15, 2014, the “Purchase
Agreement”); and

WHEREAS,
pursuant to Section 7.9 of the Purchase Agreement and subject to the terms and conditions contained herein, the parties hereto
desire to amend the Purchase Agreement as set forth herein for the purposes of, among other things, (i) decreasing the minimum
cash balance requirement set forth in Section 5.3 thereof from $5,000,000 to $2,000,000 and (ii) modifying the parties required
to amend, modify, terminate or waive the Purchase Agreement set forth in Section 7.9 thereof.

NOW,
THEREFORE, in consideration of the mutual promises, representations, warranties and covenants contained herein and in the
Purchase Agreement, which represent integral components of the transactions contemplated hereby and thereby and shall be fully
enforceable by the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which hereby
acknowledged, the Company and the Investors mutually agree as follows:

    	 

    	 

    

1.    Definitions.
Capitalized terms used in this Amendment but not defined in this Amendment shall have the meanings ascribed to them in the Purchase
Agreement.

2.    Amendments
to Purchase Agreement.

		 a.	Section
5.3 of the Purchase Agreement is hereby amended and restated in its entirety to read as follows:
	 	 	
	 	 	“Minimum
Cash Balance. The Company shall at all times maintain a minimum cash balance of $2,000,000 in one or more financial institutions;
provided, that in the event the Company’s cash balance falls below such amount, the Company shall have thirty (30) days
to cure the resulting default and deposit sufficient funds to restore the requisite minimum cash balance (it being understood,
for the avoidance of doubt, that so long as any Notes are outstanding, such thirty day period shall run concurrently and not consecutively
with any similar cure period afforded under the Notes, and shall not extend any period under the Notes for purposes of determining
whether an Event of Default, as defined in the Notes, has occurred).”
	 		 
	 	 b.	Section
7.9 of the Purchase Agreement is hereby amended and restated in its entirety to read as follows:
	 	 	 
	 	 	“Amendments,
Modifications, Terminations and Waivers. The terms and provisions of this Agreement and the Closing Securities may not be
modified, amended or terminated, nor may any of the provisions hereof be waived, temporarily or permanently, except pursuant to
a written instrument executed by both the Company and the Investors holding a majority of the shares of Common Stock issued or
issuable (on an as converted basis) upon conversion of the Notes and Warrants by any Investor, for so long as any Investor continues
to hold such Notes, Warrants or the underlying shares of Common Stock. The parties expressly acknowledge and agree that the representations
and warranties and the covenants contained herein constitute an integral component of the transactions contemplated by the this
Agreement and the Transaction Documents and the parties hereto shall be entitled to withhold their consent in their sole and absolute
discretion with respect to any future requests for waivers of and/or modifications to such representations, warranties and covenants
(it being understood and affirmed that it is the intent of the parties that the affirmative and negative covenants of the Company
in Articles 5 and 6 shall continue to apply following the conversion of the Notes and exercise of the Warrants, for so long as
any Investor continues to hold Note Shares or Warrant Shares, as the case may be).”

    	-2-

    	 

    

 

3.    Waivers.
The parties hereto agree and acknowledge that (i) the covenants set forth in Section 5.3 of the Purchase Agreement were intended
to benefit the HealthCor Parties, (ii) the Company has at certain times been in breach of Section 5.3 of the Purchase Agreement,
(iii) prior to December 15, 2014, the HealthCor Parties have previously waived such breaches (the “Prior Waivers”),
and (iv) in consideration for the Prior Waivers, the Company is issuing to the HealthCor Parties as of the date hereof a warrant
for the purchase of 1,000,000 shares of the Company’s Common Stock with an exercise price of $0.53 and an expiration date
of March 31, 2025 (the “Additional HealthCor Warrant”). The Investors hereby agree and consent to (i) any such
Prior Waiver that was granted at a time when such Investor was a party to the Purchase Agreement, with such agreement and consent
effective as of the date of such Prior Waiver, (ii) the issuance of the Additional HealthCor Warrant as consideration for the
Prior Waivers, and (iii) this paragraph satisfying the requirements of the Purchase Agreement with regards to the granting of
the Prior Waivers. Furthermore, the Investors hereby waive in full, without any additional consideration, (i) with regards to
the issuance of the Additional HealthCor Warrant, their rights set forth under Section 5.4 (“Preemptive Rights”) of
the Purchase Agreement, including, without limitation, any notice rights thereunder and (ii) any breaches by the Company of Section
5.3 of the Purchase Agreement on or subsequent to December 15, 2014.

4.    No
Further Amendments. Except as amended by this Amendment, the Purchase Agreement shall remain in full force and effect in accordance
with its terms.

5.    Acknowledgement
and Undertaking by Company. The Company agrees and acknowledges that the transactions described in this Amendment and the
issuance of the Additional HealthCor Warrant and shares of Common Stock upon exercise or conversion of the Additional HealthCor
Warrant are intended to be exempt from Section 16(b) of the Exchange Act pursuant to one or more rules promulgated thereunder,
applicable law and the Commission’s releases and interpretations, and will, from time to time as and when requested by the
Investors, and will cause its successors and assigns to, execute and deliver or cause to be executed and delivered, to the extent
it may lawfully do so, all such documents and instruments and take, or cause to be taken, to the extent it may lawfully do so,
all such further actions as the Investors may reasonably deem necessary and desirable to facilitate and effect any such exemption.

    	-3-

    	 

    

 

6.    Miscellaneous.

a.    Ratification
and Confirmation. The Company acknowledges, agrees and confirms that: (x) the Purchase Agreement and each of the other Transaction
Documents, as amended and otherwise modified by the amendments and other modifications specifically provided herein or contemplated
hereby, are and shall continue to be in full force and effect and are hereby in all respects ratified and confirmed; and (y) without
limiting the generality of the foregoing clause (x), (i) all obligations, liabilities and Indebtedness of the Company under the
Transaction Documents, as amended hereby, constitute “Obligations” (as defined in the Security Agreement) secured
by and entitled to the benefits of the security set forth in the Security Agreement and the IP Security Agreement, and the liens
and security interests granted in favor of the Investors under the terms of the Security Agreement and the IP Security Agreement
are and remain perfected, effective, enforceable and valid and such liens and security interests are, in each case, a first priority
lien and security interest (except to the extent otherwise expressly permitted by the Transaction Documents) and such liens and
security interests are hereby in all respects ratified and confirmed, and (ii) the shares of Common Stock issuable upon exercise
or conversion of the Additional HealthCor Warrant shall constitute “Registrable Securities” under the Registration
Rights Agreement.

b.    Expenses.
The Company will pay and bear full responsibility for the reasonable legal fees and other out-of-pocket costs and expenses of
the Investors attributable to the negotiation and consummation of the transactions contemplated hereby.

c.    Further
Assurances. The Company shall duly execute and deliver, or cause to be duly executed and delivered, at its own cost and expense,
such further instruments and documents and to take all such action, in each case as may be necessary or proper in the reasonable
judgment of the Investors to carry out the provisions and purposes of this Amendment.

d.    Survival.
The representations, warranties, covenants and agreements made herein shall survive any investigation made by any party hereto,
the execution and delivery of this Amendment and the closing of the transactions contemplated hereby.

    	-4-

    	 

    

e.    Governing
Law. All questions concerning the construction, interpretation and validity of this Amendment shall be governed by and construed
and enforced in accordance with the domestic laws of the State of Delaware without giving effect to any choice or conflict of
law provision or rule (whether in the State of Delaware or any other jurisdiction) that would cause the application of the laws
of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of the State of Delaware
will control the interpretation and construction of this Amendment, even if under such jurisdiction’s choice of law or conflict
of law analysis, the substantive law of some other jurisdiction would ordinarily or necessarily apply.

f.    Construction.
The Company and the Investors acknowledge that the Company and its independent counsel and the Investors and their independent
counsel have jointly reviewed and drafted this document, and agree that any rule of construction and interpretation to the effect
that drafting ambiguities are to be resolved against the drafting party shall not be employed.

g.    Counterparts;
Facsimile and Electronic Signatures. This Amendment may be executed in any number of counterparts, and each such counterpart
hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. Counterpart
signatures to this Amendment delivered by facsimile or other electronic transmission shall be acceptable and binding.

h.    Headings.
The section and paragraph headings contained in this Amendment are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Amendment.

[Signature
Pages Follow]

    	-5-

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	COMPANY:
	 	 	 
	 	CareView Communications, Inc., A Nevada corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	Name:	Steven G. Johnson
	 	Title:	President
	 	 	 
	 	INVESTORS:
	 	 	 
	 	HealthCor Partners Fund, L.P.
	 	By:	HealthCor Partners Management L.P., as Manager
	 	By:	HealthCor Partners Management, G.P., LLC, as General Partner
	 	 	 
	 	By:	 /s/ Jeffrey C. Lightcap
	 	Name:	Jeffrey C. Lightcap
	 	Title:	Senior Managing Director
	 	 	 
	 	Address:	HealthCor Partners
	 	 	Carnegie Hall Towers
	 	 	152 West 57th Street
	 	 	New York, NY 10019
	 	 	 
	 	HealthCor Hybrid Offshore Master Fund, L.P.
	 	By:	HealthCor Hybrid Offshore G.P., LLC, as General Partner
	 	 	 
	 	By:	 /s/
    Joseph P. Healey
	 	Name:	Joseph P. Healey
	 	Title:	Co-CEO
	 	 	 
	 	Address:	HealthCor Partners
	 	 	Carnegie Hall Towers
	 	 	152 West 57th Street
	 	 	New York, NY 10019

  

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

 

    	

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	INVESTORS:
	 	/s/ Allen Wheeler
	 	Allen Wheeler
	 	/s/ Steven Johnson
	 	Steven Johnson
	 	/s/ James R. Higgins
	 	Dr. James R. Higgins

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

 

    	

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	INVESTORS:
	 	 	 
	 	Raymond
James & Assoc. Inc, not in its corporate capacity but solely as Custodian of the Individual Retirement Account of Sandra K
McRee. Further, all representations, warranties and covenants (including indemnities) set forth herein are being made by Sandra
K. McRee, not Raymond James & Assoc. Inc
	 	 	 
	 	By:	/s/ Robert Blain
	 	Name:	Robert Blain
	 	Title:	Custodian
	 	/s/ Sandra K. McRee
	 	Sandra K. McRee
	 	Beneficial Owner

 

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

 

    	

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	INVESTORS:
	 	/s/ Stephen Berkley
	 	Stephen Berkley
	 	/s/ Alexandra Berkley
	 	Alexandra Berkley
	 	/s/ Steven B. Epstein
	 	Steven B. Epstein
	 	/s/ Deborah L. Epstein
	 	Deborah L. Epstein
	 	/s/ Jason Peter Epstein
	 	Jason Peter Epstein
	 	/s/ Gregory Harris Epstein
	 	Gregory Harris Epstein
	 	/s/ David Epstein
	 	David Epstein

 

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

    	

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	INVESTORS:
	 	/s/ Juliann Martin
	 	Juliann Martin
	 	/s/ Jason Thompson
	 	Jason Thompson
	 	 
	 	Thompson Family Investments, LLC
	 		 

	 	By:	 
/s/ Jason Thompson                                                         
	 	Name:	Jason Thompson
	 	Title:	Manager

 

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

 

    	

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	INVESTORS:
	 	/s/ Irwin Leiber
	 	Irwin Leiber
	 	/s/ Joseph P. Healey
	 	Joseph P. Healey
	 	/s/ Arthur B. Cohen
	 	Arthur B. Cohen
	 	 
	 	SJ2, LLC
	 	 
	 	By:	/s/ Michael Mashaal
	 	Name:	Michael Mashaal
	 	Title:	Manager
	 	 	
		The Joseph P. Healey 2011 Family Trust
	 	 	 
	 	By:	/s/ Joseph L.
    Dowling III
	 	Name:	 Joseph L. Dowling III
	 	Title:	Manager

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

 

    	

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Sixth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

	 	INVESTORS:
	 		 
	 	Morgan Stanley Smith Barney LLC, not in its corporate
    capacity but solely as Custodian of the Individual Retirement Account of Jeffrey C. Lightcap.
	 	 
	 	By:	/s/ Gregory Williams
	 	Name:	Gregory Williams
	 	Title:	NTI Associate
	 	 
	 	/s/ Jeffrey C. Lightcap
	 	Jeffrey
    C. Lightcap
	 	Beneficial
Owner

	 	Jeffrey
C. Lightcap & Jane Lightcap Minor’s Present Interest Trust dated March 20th, 1997 F/B/O Bradford C. Lightcap
	 		 
	 	By:	/s/ Ira L. Schwartz
	 	Name:	Ira L. Schwartz
	 	Title:	Trustee

	 	Jeffrey
C. Lightcap & Jane Lightcap Minor’s Present Interest Trust dated March 20th, 1997 F/B/O Brian R. Lightcap
	 		 
	 	By:	/s/ Ira L. Schwartz
	 	Name:	Ira L. Schwartz
	 	Title:	Trustee
	 	 	 

	 	Jeffrey
C. Lightcap & Jane Lightcap Minor’s Present Interest Trust dated March 20th, 1997 F/B/O Megan M. Lightcap
	 		 
	 	By:	/s/ Ira L. Schwartz
	 	Name:	Ira L. Schwartz
	 	Title:	Trustee

 

 

[SIGNATURE
PAGE TO SIXTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT]

 

    	

    	 

    

 

	ACKNOWLEDGED
AND AGREED:
	 	 
	CareView Communications, Inc., a Texas corporation

 

	By:	/s/ Steven G, Johnson	 
	Name:	Steven G. Johnson
	Title:	President and CEO
	 	 

	CareView
Operations, LLC
	 	 
	By:	/s/ Steven G. Johnson	 
	Name:	Steven G. Johnson
	Title:	President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]